Ball, P <br/><br/>
Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections.  [electronic resource] 

 -  International journal of antimicrobial agents  Jul 2001 
 - 19-27 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0924-8579 
<br/><br/><label>Standard No.: </label>10.1016/s0924-8579(01)00359-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Infective Agents--administration & dosage<br/>Bronchitis--drug therapy<br/>Chronic Disease<br/>Community-Acquired Infections--drug therapy<br/>Drug Administration Schedule<br/>Female<br/>Fluoroquinolones<br/>Gemifloxacin<br/>Gram-Negative Bacterial Infections--drug therapy<br/>Haemophilus Infections--drug therapy<br/>Humans<br/>Klebsiella Infections--drug therapy<br/>Male<br/>Middle Aged<br/>Naphthyridines--administration & dosage<br/>Pneumococcal Infections--drug therapy<br/>Pneumonia, Bacterial--drug therapy<br/>Staphylococcal Infections--drug therapy<br/>Treatment Failure